Stock Market Today: Dow Rallies to a Record as Oracle Weighs on Nasdaq

The Federal Reserve has announced a quarter-point interest rate cut, reducing the target range to 3.5% to 3.75%. This decision is expected to provide some relief to borrowers, although it is noted that long-term payments may not see significant changes as they are influenced by other factors beyond the Fed's benchmark rates.

Analysts have revised Oracle's stock price target following a significant decline in its stock value after the company reported disappointing quarterly earnings. The earnings report revealed revenues that fell short of expectations, leading to a notable drop in premarket trading and raising concerns about Oracle's financial health.

Wall Street is experiencing fresh concerns regarding artificial intelligence (AI) spending, as shares of Broadcom and Oracle have declined significantly, contributing to a volatile week for the markets. Broadcom's stock fell sharply after failing to meet investor expectations, while Oracle's disappointing earnings report further exacerbated the situation.

Aspire Biopharma has received an extension from Nasdaq to meet its listing requirements, allowing the company additional time to comply with the exchange's standards. This extension is crucial for maintaining its status on the Nasdaq stock exchange, which is vital for its visibility and access to capital markets.

Evercore ISI has reiterated its stock rating for Oracle amid the company's ongoing expansion of data centers, signaling confidence in Oracle's strategic direction. This decision comes as Oracle continues to invest heavily in infrastructure to support its artificial intelligence initiatives.

The Nasdaq and Russell 2000 indices experienced a decline of over 1% on December 12, 2025, continuing a downward trend in the technology sector. This negative sentiment reflects ongoing concerns among investors regarding the stability and future performance of tech stocks.

VSee Health's stock has seen a significant increase following the company's successful regaining of compliance with Nasdaq's listing requirements. This development marks a positive turnaround for the company, which had previously faced challenges regarding its stock status on the exchange.

Nasdaq has submitted a new plan that grants it enhanced authority to block initial public offerings (IPOs) that are deemed vulnerable to market manipulation. This initiative aims to strengthen regulatory oversight and protect investors from potential fraud in the IPO process.